Urgent.News

What's breaking now, across thousands of outlets.

Business

Medizinprodukte: Bosch baut die Maschine, die Elizabeth Holmes nie bauen konnte

Der Technologiekonzern tüftelt an einer Wundermaschine für die Medizin. Das ehrgeizige Ziel: Krebs im Blut erkennen – und ein großes Geschäft jenseits des Autos aufbauen.

Medizinprodukte: Bosch baut die Maschine, die Elizabeth Holmes nie bauen konnte

Bosch is not fond of the comparison to Elizabeth Holmes, but they will not let it pass. Despite the similarities, Bosch aims to surpass Holmes' ambitions. In the early 2010s, Holmes, a drop-out student, introduced a medical device called Edison. Edison, no larger than a coffee machine, aimed to replace numerous medical tests and diagnoses with a few drops of blood from a person's fingertip.

Patients could view their cholesterol levels, diabetes risks, and even potential cancer within minutes. Holmes claimed her invention could save lives through early diagnoses without the need for expensive labs. However, the reality turned out to be a massive deception. Almost a decade after Holmes' downfall, another machine identical in size to a coffee machine has emerged in Waiblingen, Stuttgart.

Its name is Vivalytic. While it also promises to diagnose cancer with a few drops of blood and a short waiting time, the resemblance ends there.

Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at handelsblatt.com →

More in Business

South Korea, U.S. Hold First 2+2 Meeting at Bangkok

The heads of the finance and monetary authorities of South Korea and the United States held a four-way meeting in a “2+2” format for the first time.

  • South Korea and U.S. held first 2+2 meeting in Bangkok on October 16
  • Meeting aimed to strengthen coordination between fiscal and monetary policies
  • Focus on sharing economic conditions and cooperative measures

U.S. Foundry Race Intensifies Among Global Firms

The movement of global companies seeking to expand their foundry production facilities in the United States is accelerating.

  • TSMC investing $265 billion in Arizona for AI and HPC production
  • Japan to invest up to $21 billion in two semiconductor plants in New York
  • GlobalFoundries to operate plants for at least 20 years with 4% U.S. government stake

More from Friday 16 October →